https://www.selleckchem.com/pr....oducts/SB-203580.htm
001), and transferrin saturation (WMD -5.57; 95% CI -8.53 to -2.61; p 0.001). Meanwhile, there was no evidence of effect on serum iron (WMD 1.60; 95% CI -3.72 to 6.93; p = 0.55), nor on the incidence of adverse events (AEs) (RR 1.06; 95% CI 0.99-1.15; p = 0.51) or of serious adverse events (SAEs) (RR 1.14; 95% CI 0.88-1.46; p = 0.32). HIF-PHIs ameliorate renal anemia and rectify iron metabolism in the short term without increasing the incidence of AEs and SAEs. HIF-PHIs ameliorate renal anemia and rectify iron metabolism in the s
پسندیدن
اظهار نظر
اشتراک گذاری
